SciELO - Scientific Electronic Library Online

vol.30 número2Alteración de la variabilidad del ritmo cardíaco en pacientes con síndrome coronario agudo sin supradesnivel del segmento ST: Experiencia preliminarAcceso radial durante la angioplastía primaria en el infarto agudo al miocardio índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados



Links relacionados


Revista chilena de cardiología

versión On-line ISSN 0718-8560


ROSALES Z, Alexy  y  SALAZAR, Luis A. Effect of ABCB1 and CYP3A4 gene polymorphisms on the therapeutic response to atorvastatin in Chilean hypercholesterolemic individuals. Rev Chil Cardiol [online]. 2011, vol.30, n.2, pp.113-122. ISSN 0718-8560.

Background: : statins are effective in the control of hypercholesterolemia. However, the therapeutic response to these drugs presents a great inter-individual variability. Factors such as age, gender and ethnicity have been associated to this variability. Recent studies show that polymorphisms can influence the lipid-lowe-ring response to statins. The aim of the present study was to investigate the effect of three polymorphisms 3435C>T (ABCB1), 2677G>A/T (ABCB1) and -290 A>G (CYP3A4) gene on the response to atorvastatin treatment in Chilean hypercholesterolemic individuals. Methods: 94 hypercholesterolemic individuals, were treated with atorvastatin, 10mg/day for 4 weeks. We determined serum levels of total cholesterol, HDL-c, LDL-c and triglycerides, before and after treatment. The polymorphisms were analyzed by PCR-RFLP. Results: Significant reductions were observed in total cholesterol (275 ± 18 vs. 235 ± 22 mg/dL, p<0.001), LDL-c (183 ± 16 vs. 146 ± 24 mg/dL, p<0.001) and triglycerides levels (225 ± 48 vs. 172 ± 51 mg/dL, polymorphisms on the therapeutic hypercholesterolemic individuals p<0.001). In addition, an increase in the HDL-C levels was observed (47 ± 10 vs. 55 ± 7, p<0.001). The genotype distribution for 3535C>T variant of ABCB1 gene was: CC=47.9%, CT=41.5% and TT=10.6%. The genotype distribution for 2677G>A/T polymorphism (ABCB1) was AA=1.1%, GA=14.9%, GT=28.7%, TA=9.6%, TT=8.5% and GG=37.2%. The genotype distribution for -290A>G variant of CYP3A4 gene was: AA=77.7%. AG=22.3% and GG=0.0 %. Subjects carrying the G allele for the -290 A>G variant of the CYP3A4 gene, exhibited a greater reduction in total cholesterol (p=0.001) and LDL-C levels (p<0.001). No differences were observed for the other polymorphisms studied. Conclusion: This study suggests that the therapeutic response to atorvastatin (10mg/day during 4 weeks) is influenced by the -290 A>G variant of CYP3A4 gene.

Palabras clave : Polymorphisms; CYP3A4; atorvastatin; ABCB1.

        · resumen en Español     · texto en Español     · Español ( pdf )


Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons